Study of Monzosertib In Patients With R/R AML Or High-Risk Myelodysplastic Syndrome

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
The goal of this clinical research study is to find the recommended dose of monzosertib in patients with relapsed/refractory AML and high-risk MDS. The safety and effects of monzosertib will also be studied.
Epistemonikos ID: 0009bfba319e2e5d021e1e085c2873bf593ebcfe
First added on: Aug 21, 2026